{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:39:12Z","timestamp":1791275952364,"version":"4.1.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,8,29]],"date-time":"2012-08-29T00:00:00Z","timestamp":1346198400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1007\/s10875-012-9774-0","type":"journal-article","created":{"date-parts":[[2012,8,28]],"date-time":"2012-08-28T05:50:57Z","timestamp":1346133057000},"page":"151-161","source":"Crossref","is-referenced-by-count":124,"title":["Levels of Circulating Th17 Cells and Regulatory T Cells in Ankylosing Spondylitis Patients with an Inadequate Response to Anti\u2212TNF-\u03b1 Therapy"],"prefix":"10.1007","volume":"33","author":[{"given":"Li","family":"Xueyi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Lina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu","family":"Zhenbiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Qing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Qiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,8,29]]},"reference":[{"issue":"12","key":"9774_CR1","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1093\/rheumatology\/keh373","volume":"43","author":"HJ Baek","year":"2004","unstructured":"Baek HJ, Shin KC, et al. Clinical features of adult-onset ankylosing spondylitis in Korean patients: patients with peripheral joint disease (PJD) have less severe spinal disease course than those without PJD. Rheumatology (Oxford). 2004;43(12):1526\u201331.","journal-title":"Rheumatology (Oxford)"},{"issue":"9570","key":"9774_CR2","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0140-6736(07)60635-7","volume":"369","author":"J Braun","year":"2007","unstructured":"Braun J, Sieper J. Ankylosing spondylitis. Lancet. 2007;369(9570):1379\u201390.","journal-title":"Lancet"},{"key":"9774_CR3","doi-asserted-by":"crossref","unstructured":"Szalay B, M\u00e9sz\u00e1ros G, Cseh \u00c1, \u00c1cs L, De\u00e1k M, Kov\u00e1cs L, V\u00e1s\u00e1rhelyi B, Balog A. Adaptive immunity in ankylosing spondylitis: phenotype and functional alterations of T-cells before and during infliximab therapy. Clin Dev Immunol. 2012;2012:808724. Epub 2011 Sep 28.","DOI":"10.1155\/2012\/808724"},{"issue":"11","key":"9774_CR4","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/ng.2007.17","volume":"39","author":"PR Burton","year":"2007","unstructured":"Burton PR, Clayton DG, Cardon LR, Craddock N, Deloukas P, Duncanson A, et al. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet. 2007;39(11):1329\u201337.","journal-title":"Nat Genet"},{"issue":"10","key":"9774_CR5","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1136\/ard.2007.080283","volume":"67","author":"B Rueda","year":"2008","unstructured":"Rueda B, Orozco G, Raya E, Fernandez-Sueiro JL, Mulero J, Blanco FJ, et al. The IL23R Arg381Gln non-synonymous polymorphism confers susceptibility to ankylosing spondylitis. Ann Rheum Dis. 2008;67(10):1451\u20134.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"9774_CR6","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1093\/rheumatology\/ken501","volume":"48","author":"T Karaderi","year":"2009","unstructured":"Karaderi T, Harvey D, Farrar C, Appleton LH, Stone MA, Sturrock RD, et al. Association between the interleukin 23 receptor and ankylosing spondylitis is confirmed by a new UK case\u2013control study and meta-analysis of published series. Rheumatology (Oxford). 2009;48(4):386\u20139.","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"9774_CR7","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/art.23389","volume":"58","author":"P Rahman","year":"2008","unstructured":"Rahman P, Inman RD, Gladman DD, Reeve JP, Peddle L, Maksymowych WP. Association of interleukin-23 receptor variants with ankylosing spondylitis. Arthritis Rheum. 2008;58(4):1020\u20135.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"9774_CR8","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1002\/art.24568","volume":"60","author":"H Shen","year":"2009","unstructured":"Shen H, Goodall JC, Hill Gaston JS. Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis. Arthritis Rheum. 2009;60(6):1647\u201356.","journal-title":"Arthritis Rheum"},{"issue":"8","key":"9774_CR9","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1002\/art.23655","volume":"58","author":"C Jandus","year":"2008","unstructured":"Jandus C, Bioley G, Rivals JP, Dudler J, Speiser D, Romero P. Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritides. Arthritis Rheum. 2008;58(8):2307\u201317.","journal-title":"Arthritis Rheum"},{"issue":"7090","key":"9774_CR10","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","volume":"441","author":"E Bettelli","year":"2006","unstructured":"Bettelli E, Carrier Y, Gao W, Korn T, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006;441(7090):235\u20138.","journal-title":"Nature"},{"key":"9774_CR11","doi-asserted-by":"crossref","unstructured":"Wu Y, Ren M, Yang R, et al. Reduced immunomodulation potential of bone marrow-derived mesenchymal stem cells induced CCR4\u2009+\u2009CCR6\u2009+\u2009Th\/Treg cell subset imbalance in ankylosing spondylitis. Arthritis Res Ther. 2011;13(1): article R29.","DOI":"10.1186\/ar3257"},{"issue":"4","key":"9774_CR12","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ni0407-345","volume":"8","author":"E Bettelli","year":"2007","unstructured":"Bettelli E, Oukka M, Kuchroo VK. Th-17 cells in the circle of immunity and autoimmunity. Nat Immunol. 2007;8(4):345\u201350.","journal-title":"Nat Immunol"},{"issue":"3","key":"9774_CR13","first-page":"515","volume":"35","author":"S Agarwal","year":"2008","unstructured":"Agarwal S, Misra R, Aggarwal A. Interleukin 17 levels are increased in juvenile idiopathic arthritis synovial fluid and induce synovial fibroblasts to produce proinflammatory cytokines and matrix metalloproteinases. J Rheumatol. 2008;35(3):515\u20139.","journal-title":"J Rheumatol"},{"issue":"10","key":"9774_CR14","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/ard.61.10.870","volume":"61","author":"RL Bezooijen Van","year":"2002","unstructured":"Van Bezooijen RL, Van Der Wee-Pals L, Papapoulos SE, Lowik CW. Interleukin 17 synergies with tumor necrosis factor alpha to induce cartilage destruction in vitro. Ann Rheum Dis. 2002;61(10):870\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"9774_CR15","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.coi.2006.09.008","volume":"18","author":"K Kikly","year":"2006","unstructured":"Kikly K, Liu L, Na S, Sedgwick JD. The IL-23\/Th(17) axis: therapeutic targets for autoimmune inflammation. Curr Opin Immunol. 2006;18(6):670\u20135.","journal-title":"Curr Opin Immunol"},{"issue":"1","key":"9774_CR16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.it.2006.11.002","volume":"28","author":"AM Cooper","year":"2007","unstructured":"Cooper AM, Khader SA. IL-12p40: an inherently agonistic cytokine. Trends Immunol. 2007;28(1):33\u20138.","journal-title":"Trends Immunol"},{"key":"9774_CR17","doi-asserted-by":"crossref","unstructured":"Taylan A, Sari I, Kozaci DL, et al. Evaluation of the T helper 17 axis in ankylosing spondylitis. Rheumatol Int. 2011 Jul 16. [Epub ahead of print].","DOI":"10.1007\/s00296-011-1995-7"},{"issue":"3","key":"9774_CR18","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.4049\/jimmunol.179.3.1449","volume":"179","author":"S Iwamoto","year":"2007","unstructured":"Iwamoto S, Iwai S, Tsujiyama K, Kurahashi C, Takeshita K, Naoe M, Masunaga A, Ogawa Y, Oguchi K, Miyazaki A. TNF-alpha drives human CD14+ monocytes to differentiate into CD70+ dendritic cells evolving Th1 and Th17 responses. J Immunol. 2007;179(3):1449\u201357.","journal-title":"J Immunol"},{"issue":"2","key":"9774_CR19","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/art.27203","volume":"62","author":"HL Ma","year":"2010","unstructured":"Ma HL, Napierata L, Stedman N, Benoit S, Collins M, Nickerson-Nutter C, Young DA. Tumor necrosis factor \u03b1 blockade exacerbates murine psoriasis-like disease by enhancing Th17 function and decreasing expansion of Treg cells. Arthritis Rheum. 2010;62(2):430\u201340.","journal-title":"Arthritis Rheum"},{"issue":"11","key":"9774_CR20","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1084\/jem.20072707","volume":"205","author":"CA Notley","year":"2008","unstructured":"Notley CA, Inglis JJ, Alzabin S, McCann FE, McNamee KE, Williams RO. Blockade of tumor necrosis factor in collagen-induced arthritis reveals a novel immunoregulatory pathway for Th1 and Th17 cells. J Exp Med. 2008;205(11):2491\u20137.","journal-title":"J Exp Med"},{"key":"9774_CR21","doi-asserted-by":"crossref","first-page":"R72","DOI":"10.1186\/ar1941","volume":"8","author":"L Carmona","year":"2006","unstructured":"Carmona L, Gomez-Reino JJ. Survival of TNF antagonists in spondylarthritis is better than in rheumatoid arthritis. Arthritis Res Ther. 2006;8:R72.","journal-title":"Arthritis Res Ther"},{"issue":"28","key":"9774_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta11280","volume":"11","author":"C McLeod","year":"2007","unstructured":"McLeod C, Bagust A, Boland A, Dagenais P, Dickson R, Dundar Y, Hill RA, Jones A, Mujica Mota R, Walley T. Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation. Health Technol Assess. 2007;11(28):1\u2013158.","journal-title":"Health Technol Assess"},{"issue":"4","key":"9774_CR23","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.4049\/jimmunol.175.4.2721","volume":"175","author":"AB Gottlieb","year":"2005","unstructured":"Gottlieb AB, Chamian F, Masud S, Cardinale I, Abello MV, Lowes MA, Chen F, Magliocco M, Krueger JG. TNF inhibition rapidly down-regulates multiple proinflammatory pathways in psoriasis plaques. J Immunol. 2005;175(4):2721\u20139.","journal-title":"J Immunol"},{"issue":"4","key":"9774_CR24","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1007\/s10875-011-9542-6","volume":"31","author":"C Lina","year":"2011","unstructured":"Lina C, Conghua W, Nan L, Ping Z. Combined treatment of etanercept and MTX reverses Th1\/Th2, Th17\/Treg imbalance in patients with rheumatoid arthritis. J Clin Immunol. 2011;31(4):596\u2013605.","journal-title":"J Clin Immunol"},{"issue":"12","key":"9774_CR25","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1007\/s00296-009-1179-x","volume":"30","author":"C Yue","year":"2009","unstructured":"Yue C, You X, Zhao L, Wang H, Tang F, Zhang F, Zhang X, He W. The effects of adalimumab and methotrexate treatment on peripheral Th17 cells and IL-17\/IL-6 secretion in the rheumatoid arthritis patients. Rheumatol Int. 2009;30(12):1553\u20137.","journal-title":"Rheumatol Int"},{"issue":"4","key":"9774_CR26","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","volume":"27","author":"S Linden Van der","year":"1984","unstructured":"Van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984;27(4):361\u20138.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"9774_CR27","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/ard.2005.041129","volume":"65","author":"J Zochling","year":"2006","unstructured":"Zochling J, van der Heijde D, Dougados M, et al. Current evidence for the management of ankylosing spondylitis: a systematic literature review for the ASAS\/EULAR management recommendations in ankylosing spondylitis. Ann Rheum Dis. 2006;65(4):423\u201332.","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"9774_CR28","first-page":"2286","volume":"21","author":"S Garrett","year":"1994","unstructured":"Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the bath ankylosing spondylitis disease activity index. J Rheumatol. 1994;21(12):2286\u201391.","journal-title":"J Rheumatol"},{"issue":"12","key":"9774_CR29","first-page":"2281","volume":"21","author":"A Calin","year":"1994","unstructured":"Calin A, Garrett S, Whitelock H, Kennedy LG, O\u2019Hea J, Mallorie P, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the bath ankylosing spondylitis functional index. J Rheumatol. 1994;21(12):2281\u20135.","journal-title":"J Rheumatol"},{"issue":"3","key":"9774_CR30","doi-asserted-by":"crossref","first-page":"iii8","DOI":"10.1136\/ard.61.suppl_3.iii8","volume":"61","author":"J Sieper","year":"2002","unstructured":"Sieper J, Braun J, Rudwaleit M, Boonen A, Zink A. Ankylosing spondylitis: an overview. Ann Rheum Dis. 2002;61(3):iii8\u201318.","journal-title":"Ann Rheum Dis"},{"issue":"9783","key":"9774_CR31","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/S0140-6736(11)60071-8","volume":"377","author":"M Dougados","year":"2011","unstructured":"Dougados M, Baeten D. Spondyloarthritis. Lancet. 2011;377(9783):2127\u201337.","journal-title":"Lancet"},{"issue":"4","key":"9774_CR32","doi-asserted-by":"crossref","first-page":"R93","DOI":"10.1186\/ar2477","volume":"10","author":"S Shahrara","year":"2008","unstructured":"Shahrara S, Huang Q, Mandelin 2nd AM, Pope RM. TH-17 cells in rheumatoid arthritis. Arthritis Res Ther. 2008;10(4):R93.","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"9774_CR33","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s11926-007-0075-1","volume":"9","author":"E Fitch","year":"2007","unstructured":"Fitch E, Harper E, Skorcheva I, Kurtz SE, Blauvelt A. Pathophysiology of psoriasis: recent advances on IL-23 and Th17 cytokines. Curr Rheumatol Rep. 2007;9(6):461\u20137.","journal-title":"Curr Rheumatol Rep"},{"issue":"6","key":"9774_CR34","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1365-2796.2008.01950.x","volume":"263","author":"KJ Maloy","year":"2008","unstructured":"Maloy KJ. The Interleukin-23\/Interleukin-17 axis in intestinal inflammation. J Intern Med. 2008;263(6):584\u201390.","journal-title":"J Intern Med"},{"issue":"3","key":"9774_CR35","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jbspin.2006.11.005","volume":"74","author":"D Wendling","year":"2007","unstructured":"Wendling D, Cedoz JP, Racadot E, Dumoulin G. Serum IL-17, BMP-7, and bone turnover markers in patients with ankylosing spondylitis. Joint Bone Spine. 2007;74(3):304\u20135.","journal-title":"Joint Bone Spine"},{"issue":"11","key":"9774_CR36","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1007\/s00296-009-0883-x","volume":"29","author":"X Wang","year":"2009","unstructured":"Wang X, Lin Z, Wei Q, Jiang Y, Gu J. Expression of IL-23 and IL-17 and effect of IL-23 on IL-17 production in ankylosing spondylitis. Rheumatol Int. 2009;29(11):1343\u20137.","journal-title":"Rheumatol Int"},{"issue":"3","key":"9774_CR37","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1136\/ard.2009.107649","volume":"69","author":"L Melis","year":"2010","unstructured":"Melis L, Vandooren B, Kruithof E, Jacques P, De Vos M, Mielants H, et al. Systemic levels of IL-23 are strongly associated with disease activity in rheumatoid arthritis but not spondyloarthritis. Ann Rheum Dis. 2010;69(3):618\u201323.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"9774_CR38","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jconrel.2009.12.015","volume":"149","author":"T Nomura","year":"2011","unstructured":"Nomura T, Abe Y, Kamada H, Shibata H, Kayamuro H, Inoue M, Kawara T, Arita S, Furuya T, Yamashita T, Nagano K, Yoshikawa T, Yoshioka Y, Mukai Y, Nakagawa S, Taniai M, Ohta T, Serada S, Naka T, Tsunoda S, Tsutsumi Y. Therapeutic effect of PEGylated TNFR 1-selective antagonistic mutant TNF in experimental autoimmune encephalomyelitis mice. J Control Release. 2011;149(1):8\u201314.","journal-title":"J Control Release"},{"issue":"4","key":"9774_CR39","doi-asserted-by":"crossref","first-page":"R784","DOI":"10.1186\/ar1733","volume":"7","author":"K Raza","year":"2005","unstructured":"Raza K, Falciani F, Curnow SJ, Ross EJ, Lee CY, Akbar AN, Lord JM, Gordon C, Buckley CD, Salmon M. Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cells and stromal cell origin. Arthritis Res Ther. 2005;7(4):R784\u201395.","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"9774_CR40","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1084\/jem.20061775","volume":"203","author":"K Sato","year":"2006","unstructured":"Sato K, Suematsu A, Okamoto K, Yamaguchi A, Morishita Y, Kadono Y, Tanaka S, Kodama T, Akira S, Iwakura Y, Cua DJ, Takayanagi H. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med. 2006;203(12):2673\u201382.","journal-title":"J Exp Med"},{"issue":"7","key":"9774_CR41","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.4049\/jimmunol.160.7.3513","volume":"160","author":"DV Jovanovic","year":"1998","unstructured":"Jovanovic DV, Di Battista JA, Martel-Pelletier J, Jolicoeur FC, He Y, Zhang M, Mineau F, Pelletier JP. IL-17 stimulates the production of proinflammatory cytokines, IL-1\u03b2 and TNF-\u03b1, by human macrophages. J Immunol. 1998;160(7):3513\u201321.","journal-title":"J Immunol"},{"issue":"9","key":"9774_CR42","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1002\/1529-0131(200109)44:9<2176::AID-ART371>3.0.CO;2-4","volume":"44","author":"Y Katz","year":"2001","unstructured":"Katz Y, Nadiv O, Beer Y. Interleukin-17 enhances tumor necrosis factor alpha-induced synthesis of interleukins1, 6, and 8 in skin and synovial fibroblasts: a possible role as a \u201cfine-tuning cytokine\u201d in inflammation processes. Arthritis Rheum. 2001;44(9):2176\u201384.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"9774_CR43","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1084\/jem.20041257","volume":"201","author":"CL Langrish","year":"2005","unstructured":"Langrish CL, Chen Y, et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med. 2005;201(2):233\u201340.","journal-title":"J Exp Med"},{"issue":"11","key":"9774_CR44","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","volume":"6","author":"LE Harrington","year":"2005","unstructured":"Harrington LE, Hatton RD, et al. Interleukin 17-producing CD4 effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol. 2005;6(11):1123\u201332.","journal-title":"Nat Immunol"},{"issue":"9","key":"9774_CR45","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/ni1488","volume":"8","author":"L Zhou","year":"2007","unstructured":"Zhou L, Ivanov II, Spolski R, Min R, Shenderov K, Egawa T, Levy DE, Leonard WJ, Littman DR. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol. 2007;8(9):967\u201374.","journal-title":"Nat Immunol"},{"issue":"2","key":"9774_CR46","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/ar2392","volume":"10","author":"S Romagnani","year":"2008","unstructured":"Romagnani S. Human Th17 cells. Arthritis Res Ther. 2008;10(2):206.","journal-title":"Arthritis Res Ther"},{"issue":"9","key":"9774_CR47","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1002\/art.22866","volume":"56","author":"Z Chen","year":"2007","unstructured":"Chen Z, Tato CM, Muul L, Laurence A, \u00d3Shea JJ. Distinct regulation of interleukn-17 in human T helper lymphocytes. Arthritis Rheum. 2007;56(9):2936\u201346.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"9774_CR48","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.pharmthera.2007.10.001","volume":"117","author":"D Tracey","year":"2008","unstructured":"Tracey D, Klareskog L, Sasso EH, Salfeld JG, Tak PP. Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. Pharmacol Ther. 2008;117(2):224\u201379.","journal-title":"Pharmacol Ther"},{"issue":"5","key":"9774_CR49","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.cytogfr.2004.03.011","volume":"15","author":"G Eissner","year":"2004","unstructured":"Eissner G, Kolch W, Scheurich P. Ligands working as receptors: reverse signaling by members of the TNF superfamily enhances the plasticity of the immune system. Cytokine Growth Factor Rev. 2004;15(5):353\u201366.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"2","key":"9774_CR50","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1053\/j.gastro.2004.11.060","volume":"128","author":"H Mitoma","year":"2005","unstructured":"Mitoma H, Horiuchi T, Hatta N, Tsukamoto H, Harashima S, Kikuchi Y, et al. Infliximab induces potent anti-inflammatory responses by outside-to-inside signals through transmembrane TNF-alpha. Gastroenterology. 2005;128(2):376\u201392.","journal-title":"Gastroenterology"},{"issue":"1","key":"9774_CR51","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/ar2107","volume":"9","author":"SK Lundy","year":"2007","unstructured":"Lundy SK, Sarkar S, Tesmer LA, Fox DA, Lundy SK, Sarkar S, Tesmer LA, Fox DA. Cells of the synovium in rheumatoid arthritis. T lymphocytes. Arthritis Res Ther. 2007;9(1):202\u201312.","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"9774_CR52","doi-asserted-by":"crossref","first-page":"5350","DOI":"10.4049\/jimmunol.0802645","volume":"183","author":"J Zhang","year":"2009","unstructured":"Zhang J, Wang X, Fahmi H, Wojcik S, Fikes J, Yu Y, Wu J, Luo H. Role of TL1A in the pathogenesis of rheumatoid arthritis. J Immunol. 2009;183(8):5350\u20137.","journal-title":"J Immunol"},{"issue":"8\u20139","key":"9774_CR53","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/j.molimm.2009.01.004","volume":"46","author":"M Goldberg","year":"2009","unstructured":"Goldberg M, Nadiv O, Luknar-Gabor N, Agar G, Beer Y, Katz Y. Synergism between tumor necrosis factor alpha and interleukin-17 to induce IL-23 p19 expression in fibroblast-like synoviocytes. Mol Immunol. 2009;46(8\u20139):1854\u20139.","journal-title":"Mol Immunol"},{"issue":"5","key":"9774_CR54","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.crohns.2011.10.010","volume":"6","author":"K Ogawa","year":"2012","unstructured":"Ogawa K, Matsumoto T, Esaki M, Torisu T, Iida M. Profiles of circulating cytokines in patients with Crohn\u2019s disease under maintenance therapy with infliximab. J Crohns Colitis. 2012;6(5):529\u201335.","journal-title":"J Crohns Colitis"},{"issue":"3","key":"9774_CR55","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.4049\/jimmunol.163.3.1521","volume":"163","author":"P Charles","year":"1999","unstructured":"Charles P, Elliott MJ, Davis D, Potter A, Kalden JR, Antoni C, et al. Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-\u03b1 therapy in rheumatoid arthritis. J Immunol. 1999;163(3):1521\u20138.","journal-title":"J Immunol"},{"issue":"3","key":"9774_CR56","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1084\/jem.20040165","volume":"200","author":"MR Ehrenstein","year":"2004","unstructured":"Ehrenstein MR, Evans JG, et al. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J Exp Med. 2004;200(3):277\u201385.","journal-title":"J Exp Med"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-012-9774-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-012-9774-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-012-9774-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,25]],"date-time":"2023-06-25T13:00:44Z","timestamp":1687698044000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-012-9774-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,29]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["9774"],"URL":"https:\/\/doi.org\/10.1007\/s10875-012-9774-0","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,29]]}}}